Deze website maakt gebruik van cookies. We gebruiken cookies om instellingen te onthouden en je bezoek soepeler te laten verlopen. Daarnaast gebruiken we ook cookies voor de verbetering van de website en het verzamelen en analyseren van statistieken. Lees meer over cookies

Home
Sebastiaan van Heesch

Sebastiaan van Heesch

Principal Investigator

Van Heesch Groep

Telefoon 31 (0) 88 97 25 186

E-mail s.a.a.vanheesch@prinsesmaximacentrum.nl

Microproteins in cancer
- okt. 2024
- Damon A, Hofman, et al
- Trends in Genetics
High-quality peptide evidence for annotating non-canonical open reading frames as human proteins
- sep. 2024
- Eric W, Deutsch, et al
- bioRxiv : the preprint server for biology
Targeting pediatric cancers via T-cell recognition of the monomorphic MHC class I-related protein MR1
- mrt. 2024
- Annelisa M, Cornel, et al
- Journal for ImmunoTherapy of Cancer
Translation of non-canonical open reading frames as a cancer cell survival mechanism in childhood medulloblastoma
- jan. 2024
- Damon A, Hofman, et al
- Molecular Cell
What can Ribo-seq and proteomics tell us about the non-canonical proteome?
- mei 2023
- John R, Prensner, et al
- bioRxiv

Bekijk alle publicaties

Sebastiaan van Heesch

Publicaties

Microproteins in cancer

High-quality peptide evidence for annotating non-canonical open reading frames as human proteins

Targeting pediatric cancers via T-cell recognition of the monomorphic MHC class I-related protein MR1

Translation of non-canonical open reading frames as a cancer cell survival mechanism in childhood medulloblastoma

What can Ribo-seq and proteomics tell us about the non-canonical proteome?